Health & Wellness Today New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.

Press releases published on March 5, 2026

Mar. 5, 2026

Get Me Out of Here! Offers a Safety-First Roadmap for Women Leaving Toxic Relationships

Indeterminate EIN Presswire

Mar. 5, 2026

World Parkinson Coalition® Announces Top 10 Films in WPC 2026 Short Film Competition; Vote for People’s Choice Award

Indeterminate EIN Presswire

Mar. 5, 2026

Lighthouse Dental in Greece NY Provides Family & Cosmetic Dentistry With Dr. Wierchowski

Indeterminate EIN Presswire

Mar. 5, 2026

The Brookbush Institute Publishes a NEW Glossary Term: 'Muscular Endurance'

Indeterminate EIN Presswire

Mar. 5, 2026

OmniMD Unveils AI-Driven Clinical–Financial Architecture for Revenue Intelligence

Indeterminate EIN Presswire

Mar. 5, 2026

Calidi Biotherapeutics Announces Proposed Public Offering

Indeterminate GlobeNewswire

Mar. 5, 2026

President & CEO Letter to Shareholders

Indeterminate GlobeNewswire

Mar. 5, 2026

Nova Leap Health Corp. Posts Fourth Quarter and Record Full-Year 2025 Revenues and Adjusted EBITDA

Indeterminate GlobeNewswire

Mar. 5, 2026

COSCIENS Provides Strategic Update

Indeterminate GlobeNewswire

Mar. 5, 2026

MediWound Files Annual Report on Form 20-F

Indeterminate GlobeNewswire

Mar. 5, 2026

MannKind Announces Settlement of Convertible Senior Notes

Indeterminate GlobeNewswire

Mar. 5, 2026

New Book “Avoiding Toxins” Offers a Physician’s Practical Playbook for Navigating America’s Hidden Environmental Exposure Crisis

Indeterminate GlobeNewswire

Mar. 5, 2026

Kyverna Therapeutics to Present New Data from Neuroimmunology Franchise at AAN 2026

Indeterminate GlobeNewswire

Mar. 5, 2026

CooperCompanies Announces First Quarter 2026 Results

Indeterminate GlobeNewswire

Mar. 5, 2026

Tonix Pharmaceuticals Announces Publication of Clinical Pharmacokinetic Studies of TONMYA™ and Prototype Formulations in the Journal Clinical Pharmacology in Drug Development

Indeterminate GlobeNewswire

Mar. 5, 2026

Outlook Therapeutics Provides Update Following Type A Meeting with FDA Regarding ONS-5010/LYTENAVA™ (bevacizumab-vikg)

Indeterminate GlobeNewswire

Mar. 5, 2026

Omada Health Announces GLP-1 Flex Care, Giving Employers a New, Flexible Path to Support Obesity Care

Indeterminate GlobeNewswire

Mar. 5, 2026

Nyxoah Publiera ses Résultats Financiers du Quatrième Trimestre et de l’Année 2025 le 19 Mars 2026

Indeterminate GlobeNewswire

Mar. 5, 2026

Nyxoah to Release Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026

Indeterminate GlobeNewswire

Mar. 5, 2026

CAMP4 Reports Full Year 2025 Financial Results and Corporate Highlights

Indeterminate GlobeNewswire